Page 7 of 8
ACS Medicinal Chemistry Letters
reactions of organoboron compounds. Chem. Rev. 1995, 95,
2457–2483.
against β-lactam-resistant Staphylococcus aureus. ACS Infect
Dis. 2018, 4, 1508–1518.
38. Vornhagen, J.; Burnside, K.; Whidbey, C.; Berry, J.; Qin, X.;
Rajagopal, L. Kinase inhibitors that increase the sensitivity of
methicillin resistant Staphylococcus aureus to β-lactam
antibiotics. Pathogens 2015, 4, 708–721.
39. Zheng, W.; Cai, X.; Li, S.; Li, Z. Autophosphorylation
mechanism of the Ser/Thr kinase Stk1 from Staphylococcus
aureus. Front. Microbiol. 2018, 9, 758.
40. Pensinger, D. A.; Schaenzer, A. J.; Sauer, J. D. Do shoot the
messenger: PASTA kinases as virulence determinants and
antibiotic targets. Trends Microbiol. 2018, 26, 56–69.
41. Kristich, J. C.; Wells, L. C.; Dunny, M. G. A eukaryotic-type
Ser/Thr kinase in Enterococcus faecalis mediates antimicrobial
resistance and intestinal persistence. Proc. Natl. Acad. Sci.
U.S.A. 2007, 104, 3508–3513.
42. Beltramini, A. M.; Mukhopadhyay, C. D.; Pancholi, V.
Modulation of cell wall structure and antimicrobial
susceptibility by a Staphylococcus aureus eukaryote-like
serine/threonine kinase and phosphatase. Infect. Immun.
2009, 77, 1406–1416.
43. Tamber, S.; Schwartzman, J.; Cheung, A. L. Role of PknB kinase
in antibiotic resistance and virulence in community-acquired
methicillin-resistant Staphylococcus aureus strain USA300.
Infect. Immun. 2010, 78, 3637–3646.
44. Soulat, D.; Jault, J. M.; Duclos, B.; Geourjon, C.; Cozzone, A. J.;
Grangeasse, C. Staphylococcus aureus operates protein-
tyrosine phosphorylation through a specific mechanism. J.
Biol. Chem. 2006, 281, 14048–14056.
45. Dangel, A.; Ackermann, N.; Abdel-Hadi, O.; Maier, R.; Önder,
K.; Francois, P.; Müller, C. W.; Pané-Farré, J.; Engelmann, S.;
Schrenzel, J.; Heesemann, J.; Lindermayr, C. A de novo-
designed antimicrobial peptide with activity against
multiresistant Staphylococcus aureus acting on RsbW kinase.
FASEB J. 2013, 27, 4476–4488.
1
2
3
4
5
6
7
8
26. Casset, J. E.; Dunman, P. M.; McAleese, F.; Murphy, E.; Projan,
S. J.; Smeltzer, M. S. Comparative genomics of Staphylococcus
aureus musculoskeletal isolates. J. Bacteriol. 2005, 187, 576-
592.
27. McDougal, K. L.; Steward, D. C.; Killgore, E. G.; Chaitram, M. J.;
McAllister, K. S.; Tenover, C. F. Pulsed-field gel electrophoresis
typing of oxacillin-resistant Staphylococcus aureus isolates
from the United States: establishing a national database. J.
Clin. Microbiol. 2003, 41, 5113–5120.
28. CLSI. (2012) Performance Standards for Antimicrobial
Susceptibility Testing, 22nd Informational Supplement, CLSI
Document M100- S22, Clinical and Laboratory Standards
Institute, Wayne, PA, USA.
29. Baell, J. B.; Holloway, G. A. New substructure filters for
removal of Pan Assay Interference Compounds (PAINS) from
screening libraries and for their exclusion in bioassays. J. Med.
Chem. 2010, 53, 2719-2740.
31. Bonapace, C. R.; Bosso, J. A.; Friedrich, L. V.; White, R. L.
Comparison of methods of interpretation of checkerboard
synergy testing. Diagn. Microbiol. Infect. Dis. 2002, 44, 363-
366.
32. Odds, F. C. Synergy, antagonism and what the chequerboard
puts between them. J. Antimicrob. Chemother. 2003, 52, 1.
33. Orhan, G.; Bayram, A.; Zer, Y.; Balci I. Synergy tests by E test
and checkerboard methods of antimicrobial combinations
against Brucella melitensis. J. Clin. Microbiol. 2005, 43, 140-
143.
34. Mosmann, T. Rapid colorimetric assay for cellular growth and
survival: application to proliferation and cytotoxicity assays. J.
Immunol. Methods 1983, 65, 55–63.
35. Pensinger, D. A.; Aliota, M. T.; Schaenzer, A. J.; Boldon, K. M.;
Ansari, I. U.; Vincent, W. J.; Knight, B.; Reniere, M. L.; Striker, R.;
Sauer, J. D. Selective pharmacologic inhibition of a PASTA
kinase increases Listeria monocytogenes susceptibility to β-
lactam antibiotics. Antimicrob. Agents Chemother. 2014, 58,
4486–4494.
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
46. Kolar, S. L.; Nagarajan, V.; Oszmiana, A.; Rivera, F. E; Miller, H.
K.; Davenport, J. E.; Riordan, J. T.; Potempa, J.; Barber, D. S.;
Koziel, J.; Elasri, M. O.; Shaw, L. N. NsaRS is a cell-envelope-
stress-sensing two-component system of Staphylococcus
aureus. Microbiology 2011, 157, 2206–2219.
36. Schaenzer, A. J.; Wlodarchak, N.; Drewry, D. H.; Zuercher, W.
J.; Rose, W. E.; Striker, R.; Sauer J. D. A screen for kinase
47. Ventola, C. L. The Antibiotic Resistance Crisis. P. T. 2015, 40,
277–283.
inhibitors
identifies
antimicrobial
imidazopyridine
48. Deurenberg, R. H.; Stobberingh E. E. The evolution of
Staphylococcus aureus. Infect. Genet. Evol. 2008, 8, 747–763.
49. Lowy, F. D. Antimicrobial resistance: the example of
Staphylococcus aureus. J. Clin. Invest. 2003, 111, 1265–1273.
50. Harris, S. R.; Feil, E. J.; Holden, M. T.; Quail, M. A.; Nickerson, E.
K.; Chantratita, N.; Gardete, S.; Tavares, A.; Day, N.; Lindsay, J.
A.; Edgeworth J. D.; de Lencastre, H.; Parkhill, J.; Peacock, S. J.;
Bentley, S. D. Evolution of MRSA during hospital transmission
and intercontinental spread. Science 2010, 327, 469–474.
aminofurazans as specific inhibitors of the Listeria
monocytogenes PASTA kinase PrkA. J. Biol. Chem. 2017, 292,
17037–17045.
37. Schaenzer, A. J.; Wlodarchak, N.; Drewry, D. H.; Zuercher, W.
J.; Rose, W. E.; Ferrer, C. A.; Sauer, J. D.; Striker, R. GW779439X
and its pyrazolopyridazine derivatives inhibit the
serine/threonine kinase Stk1 and act as antibiotic adjuvants
7
ACS Paragon Plus Environment